Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial

Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The GETAFIX trial will test the hypothesis that favipiravir is a more effective treatment for COVID-19 infection in patients who have early stage disease, compared to current standard of care. This study will also provide an important opportunity to investigate the safety and tol...

Full description

Bibliographic Details
Main Authors: Catherine R. Hanna, Kevin G. Blyth, Glenn Burley, Samantha Carmichael, Carol Evans, Samantha Hinsley, Ibrahim Khadra, Saye Khoo, Liz-Anne Lewsley, Robert R. Jones, Raman Sharma, Andrea Taladriz-Sender, Emma C. Thomson, Janet T. Scott
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Trials
Subjects:
COVID-19
Randomised controlled trial
protocol
favipiravir
inpatient
outpatient
Online Access:http://link.springer.com/article/10.1186/s13063-020-04891-1

Internet

http://link.springer.com/article/10.1186/s13063-020-04891-1

Similar Items